Form 4: CoreWeave CFO Awarded 128,603 Restricted Stock Units
Insider Transaction Report
CoreWeave's Chief Financial Officer, Nitin Agrawal, was granted 128,603 Restricted Stock Units, aligning executive compensation with future company performance.
Summary
- Nitin Agrawal, Chief Financial Officer of CoreWeave, Inc. (CRWV), was granted 128,603 Restricted Stock Units (RSUs).
- Each RSU represents a contingent right to receive one share of CoreWeave's Class A Common Stock upon settlement.
- The transaction date for this award was February 10, 2026.
- The RSUs will vest in tranches, with 1/16th of the total award vesting on the 20th calendar day of May, August, November, and February, subject to Mr. Agrawal's continued service to the Issuer.
- The first vesting tranche is scheduled for May 20, 2026.
- These restricted stock units do not have an expiration date; they either vest or are cancelled prior to vesting.
Sentiment
Score: 7
Explanation: StockSavvy.ai views this as a moderately positive development, as it signifies a standard practice of aligning executive incentives with shareholder interests, which is generally beneficial for corporate governance and long-term performance.
Positives
- The grant of Restricted Stock Units to the Chief Financial Officer aligns management's long-term interests with those of shareholders, incentivizing sustained company performance.
- Equity-based compensation is a standard practice for retaining and motivating key executives in growth-oriented companies.
Negatives
- NA
Risks
- The vesting of the Restricted Stock Units is contingent upon the reporting person's continued service to the Issuer on each vesting date, meaning the award could be forfeited if employment ceases.
Future Outlook
The vesting schedule for the Restricted Stock Units indicates a long-term incentive structure, with equity ownership gradually increasing over time, contingent on continued service.
Industry Context
StockSavvy.ai notes that equity awards, such as Restricted Stock Units, are a prevalent form of executive compensation in the technology sector. This practice is designed to align the financial interests of key executives with the long-term performance and shareholder value creation of the company, a common strategy among high-growth tech firms.
Comparison to Industry Standards
- StockSavvy.ai observes that RSU grants with multi-year, service-based vesting schedules are standard practice for executive compensation in growth-oriented technology companies.
- This approach is comparable to compensation structures seen at major tech players like NVIDIA, AMD, or Snowflake, where equity incentives are crucial for attracting and retaining top talent and fostering long-term commitment.
Stakeholder Impact
- Shareholders: Potential for long-term value creation through aligned executive incentives; minor future dilution from RSU settlement.
- Employees: Reinforces a culture of equity-based compensation, potentially impacting morale and retention for other key personnel.
- Management: Provides a significant long-term incentive tied to company performance and continued service.
Next Steps
- The Restricted Stock Units will begin vesting on May 20, 2026, and continue quarterly thereafter, subject to the CFO's continued service.
Key Dates
| Date | Description |
|---|---|
| 02/10/2026 | Date of earliest transaction (grant of Restricted Stock Units) |
| 05/20/2026 | First tranche vesting date for the Restricted Stock Units |
| 02/12/2026 | Signature date of the reporting person's attorney-in-fact |
Keywords
CoreWeave, CRWV, Nitin Agrawal, Chief Financial Officer, Restricted Stock Units, RSU, Equity Award, Insider Transaction, Executive Compensation, Form 4
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.